We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Occidental Petroleum
OXY
$57.9B
| $54.9M | 0.13% |
880,256
-60,417
| -6% | -$4.11M |
|
202
Bank of America
BAC
$447B
| $54.8M | 0.12% |
1,658,502
-113,491
| -6% | -$3.91M |
|
203
Church & Dwight Co
CHD
$24.5B
| $54.8M | 0.12% |
679,785
+87,816
| +15% | +$6.74M |
|
|
OPTU
204
Optimum Communications Inc
OPTU
$297M
| $54.5M | 0.12% |
12,069,565
+10,106,315
| +515% | +$49.7M |
|
205
Biogen
BIIB
$30.8B
| $54.4M | 0.12% |
197,818
-56,640
| -22% | -$16M |
|
206
Moderna
MRNA
$24.2B
| $53.8M | 0.12% |
309,205
-285,180
| -48% | -$46.6M |
|
207
Avnet
AVT
$7.92B
| $53.6M | 0.12% |
1,300,740
+108,690
| +9% | +$4.52M |
|
208
KLA
KLAC
$254B
| $53.4M | 0.12% |
1,432,630
-196,830
| -12% | -$6.86M |
|
209
NextEra Energy
NEE
$176B
| $53.3M | 0.12% |
637,102
-284,047
| -31% | -$22.9M |
|
210
Lam Research
LRCX
$384B
| $53.1M | 0.12% |
1,277,280
+142,070
| +13% | +$5.94M |
|
211
Ameren
AEE
$29.7B
| $52.6M | 0.12% |
591,626
-74,014
| -11% | -$6.22M |
|
212
Acuity Brands
AYI
$10.6B
| $52.4M | 0.12% |
316,626
+65,169
| +26% | +$11.6M |
|
213
Packaging Corp of America
PKG
$22.6B
| $52.2M | 0.12% |
408,295
-239,794
| -37% | -$30.1M |
|
214
Chemours
CC
$2.23B
| $52.1M | 0.12% |
1,707,694
+40,556
| +2% | +$1.22M |
|
215
Vontier
VNT
$4.71B
| $51.6M | 0.12% |
2,715,869
+1,202,784
| +79% | +$22.5M |
|
216
AGCO
AGCO
$7.07B
| $51.1M | 0.12% |
369,802
+20,590
| +6% | +$2.54M |
|
217
Fomento Económico Mexicano
FMX
$41.3B
| $51M | 0.12% |
653,332
-184,015
| -22% | -$13.5M |
|
218
Penske Automotive Group
PAG
$14.2B
| $50.8M | 0.12% |
442,397
-43,137
| -9% | -$4.92M |
|
|
PDCE
219
DELISTED
PDC Energy, Inc.
PDCE
| $50.6M | 0.12% |
796,436
+36,950
| +5% | +$2.58M |
|
220
Goldman Sachs
GS
$303B
| $50.4M | 0.11% |
148,172
-69,491
| -32% | -$24.2M |
|
221
SS&C Technologies
SSNC
$18.7B
| $50M | 0.11% |
964,967
-88,671
| -8% | -$4.49M |
|
222
Sempra
SRE
$55.4B
| $49.9M | 0.11% |
645,776
-59,358
| -8% | -$4.59M |
|
223
Olin
OLN
$2.11B
| $49.7M | 0.11% |
938,845
-310,584
| -25% | -$16.5M |
|
224
American Electric Power
AEP
$66.9B
| $49.6M | 0.11% |
521,868
+66,922
| +15% | +$6.09M |
|
225
Travel + Leisure Co
TNL
$4.55B
| $49.3M | 0.11% |
1,375,307
+52,736
| +4% | +$1.98M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.